Literature DB >> 24119869

Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity.

Xiao-Qin Wu1, Cheng Huang1, Ying-Ming Jia1, Bao-An Song2, Jun Li3, Xin-Hua Liu4.   

Abstract

A series novel 1-(3-substituted-5-phenyl-4,5-dihydropyrazol-1-yl)-2-thio-ethanone derivatives as potential telomerase inhibitors were designed and synthesized. The bioassays demonstrated that compounds 4a, 4f, 4j and 7b, 7d occupied high antiproliferative activity against SGC-7901, MGC-803, Bcap-37 and HEPG-2 cell lines. By a modified TRAP assay, some title compounds were tested against telomerase, and compound 4f showed the most potent inhibitory activity with IC₅₀ value at 0.92 ± 0.09 μM. The mechanism of antitumor action indicated that title compounds 4f and 7b could suppress cell proliferation through inducing cell cycle arrest in G0/G1 phase.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anticancer activity; Coumarin; Dihydropyrazole; Thio-ethanone

Mesh:

Substances:

Year:  2013        PMID: 24119869     DOI: 10.1016/j.ejmech.2013.06.014

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  9 in total

1.  Synthesis and evaluation of anticancer activity of 6-pyrazolinylcoumarin derivatives.

Authors:  Yana Garazd; Myroslav Garazd; Roman Lesyk
Journal:  Saudi Pharm J       Date:  2016-06-03       Impact factor: 4.330

2.  Preparation of Enantiomeric β-(2',5'-Dimethylphenyl)Bromolactones, Their Antiproliferative Activity and Effect on Biological Membranes.

Authors:  Witold Gładkowski; Aleksandra Włoch; Aleksandra Pawlak; Angelika Sysak; Agata Białońska; Marcelina Mazur; Paweł Mituła; Gabriela Maciejewska; Bożena Obmińska-Mrukowicz; Halina Kleszczyńska
Journal:  Molecules       Date:  2018-11-20       Impact factor: 4.411

3.  Synthesis, computational study and biological evaluation of 9-acridinyl and 1-coumarinyl-1,2,3-triazole-4-yl derivatives as topoisomerase II inhibitors.

Authors:  Gehan A Abdel-Hafez; Abdel-Maaboud I Mohamed; Adel F Youssef; Claire Simons; Ahmed S Aboraia
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

4.  The ROS/GRK2/HIF-1α/NLRP3 Pathway Mediates Pyroptosis of Fibroblast-Like Synoviocytes and the Regulation of Monomer Derivatives of Paeoniflorin.

Authors:  Zhongyang Hong; Xianzheng Zhang; Tianjing Zhang; Ling Hu; Ruijin Liu; Pan Wang; Han Wang; Qianqian Yu; Dan Mei; Ziyang Xue; Feng Zhang; Lingling Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-01-29       Impact factor: 6.543

5.  Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells.

Authors:  Safaa M Kishk; Enas E Eltamany; Mohamed S Nafie; Roaa M Khinkar; Rawan H Hareeri; Sameh S Elhady; Asmaa S A Yassen
Journal:  Molecules       Date:  2022-10-09       Impact factor: 4.927

6.  Probing the origins of aromatase inhibitory activity of disubstituted coumarins via QSAR and molecular docking.

Authors:  Apilak Worachartcheewan; Naravut Suvannang; Supaluk Prachayasittikul; Virapong Prachayasittikul; Chanin Nantasenamat
Journal:  EXCLI J       Date:  2014-12-08       Impact factor: 4.068

Review 7.  Pyrazoline Hybrids as Promising Anticancer Agents: An Up-to-Date Overview.

Authors:  Dimitris Matiadis; Marina Sagnou
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

8.  Design, synthesis and biological evaluation of tricyclic pyrazolo[1,5-c][1,3]benzoxazin-5(5H)-one scaffolds as selective BuChE inhibitors.

Authors:  Guo-Liang Qiu; Shao-Sheng He; Shi-Chao Chen; Bo Li; Hui-Hui Wu; Jing Zhang; Wen-Jian Tang
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

9.  Design of Fluorescent Coumarin-Hydroxamic Acid Derivatives as Inhibitors of HDACs: Synthesis, Anti-Proliferative Evaluation and Docking Studies.

Authors:  Santiago García; Itzel Mercado-Sánchez; Luis Bahena; Yolanda Alcaraz; Marco A García-Revilla; Juvencio Robles; Nancy Santos-Martínez; David Ordaz-Rosado; Rocío García-Becerra; Miguel A Vazquez
Journal:  Molecules       Date:  2020-11-04       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.